Swisspartners Ltd. Kintara Therapeutics, Inc. Transaction History

Swisspartners Ltd.

  • $78.3 Million
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
BUY
$0.31 - $0.55 $51,150 - $90,750
165,000 Added 150.0%
275,000 $109,000
Q1 2022

May 04, 2022
SELL
$0.31 - $0.55 $51,150 - $90,750
-165,000 Reduced 60.0%
110,000 $518,000
Q1 2021

May 12, 2021
BUY
$1.32 - $2.74 $363,000 - $753,500
275,000 New
275,000 $479,000

About Kintara Therapeutics, Inc.

KTRA Quotes by TradingView
  • Ticker KTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,807,296
  • Market Cap $17.8M
  • Description
  • Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme,...
More about KTRA
Track This Portfolio

Track Swisspartners Ltd. Portfolio

Follow Swisspartners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swisspartners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Swisspartners Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email